← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

M

$ Value

$0

Shares

6,986

Price

$0

Filed

Jul 8

Insider

Name

Smith Hunter C

Title

Chief Financial Officer

CIK

0001636385

Roles

Officer

Transaction Details

Transaction Date

2025-07-07

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

70,208

Footnotes

The stock option is fully vested.

Filing Info

Accession No.

0001104659-25-066420

Form Type

4

Issuer CIK

0001649904

Smith Hunter C's History

Date Ticker Type Value
2026-02-05 RYTM $359K
2026-02-04 RYTM $157K
2026-02-04 RYTM $107K
2026-02-04 RYTM $80K
2026-02-01 RYTM M
2026-02-01 RYTM F $1.2M
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01